Cargando…
The Histone Demethylase LSD1/ΚDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program
Breast cancer is the leading cause of cancer death in the female population, despite advances in diagnosis and treatment. The highly heterogeneous nature of the disease represents a major obstacle to successful therapy and results in a significant number of patients developing drug resistance and, e...
Autores principales: | Verigos, John, Karakaidos, Panagiotis, Kordias, Dimitris, Papoudou-Bai, Alexandra, Evangelou, Zoi, Harissis, Haralampos V., Klinakis, Apostolos, Magklara, Angeliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827056/ https://www.ncbi.nlm.nih.gov/pubmed/31627418 http://dx.doi.org/10.3390/cancers11101585 |
Ejemplares similares
-
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
por: Karakaidos, Panagiotis, et al.
Publicado: (2019) -
Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
por: Kordias, Dimitris, et al.
Publicado: (2022) -
Transcriptional Profiling of Tumorspheres Reveals TRPM4 as a Novel Stemness Regulator in Breast Cancer
por: Verigos, John, et al.
Publicado: (2021) -
A Selective Phenelzine Analogue Inhibitor of Histone
Demethylase LSD1
por: Prusevich, Polina, et al.
Publicado: (2014) -
Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells
por: Hino, Shinjiro, et al.
Publicado: (2016)